Hebei Jianxin Chemical Co., Ltd. (SHE:300107)
China · Delayed Price · Currency is CNY 7.40
+0.07 (0.95%)
May 6, 2026, 3:04 PM CST
Hebei Jianxin Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 499.01 | 464.95 | 604.79 | 657.85 | 740.7 | 622.62 |
Other Revenue | 0.49 | 0.49 | 0.58 | 0.36 | 1.77 | 5.53 |
| 499.51 | 465.44 | 605.38 | 658.21 | 742.47 | 628.15 | |
Revenue Growth (YoY) | -12.26% | -23.12% | -8.03% | -11.35% | 18.20% | 11.43% |
Cost of Revenue | 457.1 | 437.24 | 549.85 | 580.04 | 625.27 | 554.21 |
Gross Profit | 42.41 | 28.2 | 55.53 | 78.17 | 117.2 | 73.94 |
Selling, General & Admin | 22.98 | 23.17 | 25.18 | 42.68 | 39.86 | 50.34 |
Research & Development | 42.4 | 39.96 | 35.67 | 35.15 | 31.81 | 28.27 |
Other Operating Expenses | 6.44 | 5.75 | 3.95 | 5.78 | 5.06 | 4.28 |
Operating Expenses | 71.43 | 68.49 | 64.48 | 83.42 | 78.19 | 82.07 |
Operating Income | -29.02 | -40.29 | -8.96 | -5.25 | 39 | -8.13 |
Interest Expense | -0.01 | -0.01 | -0.02 | -0.22 | -0.76 | -0.55 |
Interest & Investment Income | 9 | 9.19 | 13.86 | 14.75 | 16.09 | 18.53 |
Currency Exchange Gain (Loss) | -0.44 | -0.44 | 3.75 | 2.02 | 7.64 | -1.72 |
Other Non Operating Income (Expenses) | -3.86 | 0.1 | -0.3 | -0.24 | -0.22 | -0.24 |
EBT Excluding Unusual Items | -24.33 | -31.46 | 8.33 | 11.06 | 61.75 | 7.88 |
Asset Writedown | -0.97 | -0.05 | -0.24 | -0.57 | -0.34 | -0.16 |
Other Unusual Items | 1.85 | 1.85 | 3.44 | 2.95 | 2.81 | 4.29 |
Pretax Income | -23.45 | -29.65 | 11.54 | 13.43 | 64.22 | 12.01 |
Income Tax Expense | -0.67 | -1.91 | -7.83 | -1.3 | 2.95 | -1.63 |
Earnings From Continuing Operations | -22.78 | -27.74 | 19.37 | 14.73 | 61.27 | 13.64 |
Net Income | -22.78 | -27.74 | 19.37 | 14.73 | 61.27 | 13.64 |
Net Income to Common | -22.78 | -27.74 | 19.37 | 14.73 | 61.27 | 13.64 |
Net Income Growth | - | - | 31.44% | -75.96% | 349.12% | -69.95% |
Shares Outstanding (Basic) | 564 | 563 | 560 | 552 | 552 | 552 |
Shares Outstanding (Diluted) | 564 | 572 | 573 | 573 | 557 | 552 |
Shares Change (YoY) | -1.59% | -0.17% | -0.06% | 2.91% | 0.85% | 0.36% |
EPS (Basic) | -0.04 | -0.05 | 0.03 | 0.03 | 0.11 | 0.02 |
EPS (Diluted) | -0.04 | -0.05 | 0.03 | 0.03 | 0.11 | 0.02 |
EPS Growth | - | - | 31.52% | -76.64% | 345.34% | -70.06% |
Free Cash Flow | -138.25 | -115.46 | -85.92 | -2.86 | 56.07 | -59.5 |
Free Cash Flow Per Share | -0.24 | -0.20 | -0.15 | -0.01 | 0.10 | -0.11 |
Dividend Per Share | - | - | 0.016 | 0.016 | 0.060 | 0.100 |
Dividend Growth | - | - | - | -73.33% | -40.00% | - |
Gross Margin | 8.49% | 6.06% | 9.17% | 11.88% | 15.78% | 11.77% |
Operating Margin | -5.81% | -8.66% | -1.48% | -0.80% | 5.25% | -1.29% |
Profit Margin | -4.56% | -5.96% | 3.20% | 2.24% | 8.25% | 2.17% |
Free Cash Flow Margin | -27.68% | -24.81% | -14.19% | -0.43% | 7.55% | -9.47% |
EBITDA | 40.96 | 29.62 | 60.66 | 59.2 | 104.66 | 59.28 |
EBITDA Margin | 8.20% | 6.36% | 10.02% | 9.00% | 14.10% | 9.44% |
D&A For EBITDA | 69.99 | 69.91 | 69.62 | 64.46 | 65.65 | 67.41 |
EBIT | -29.02 | -40.29 | -8.96 | -5.25 | 39 | -8.13 |
EBIT Margin | -5.81% | -8.66% | -1.48% | -0.80% | 5.25% | -1.29% |
Effective Tax Rate | - | - | - | - | 4.59% | - |
Revenue as Reported | 465.44 | 465.44 | 605.38 | 658.21 | 742.47 | 628.15 |
Advertising Expenses | - | - | - | - | - | 0.03 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.